发现A-910,一种高强度,口服可生物利用的双重MerTK/Axl选择性氨酸激酶抑制剂
Yiyun Yu1, Miyeon Jang2, Julie Miyashiro1
1Abbvie, Inc, 1 North Waukegan Road, North Chicago, Illinois 60064, United States.
Journal of medicinal chemistry
|September 16, 2024
概括
研究人员发现了A-910,一种强大的双重MerTK/Axl抑制剂. 这种口服生物可用化合物通过向瘤存活和免疫抑制来显示癌症免疫治疗的前景.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 瘤受体氨酸激酶 (MerTK和Axl) 在瘤微环境中的癌细胞存活和免疫逃避中至关重要.
- 选择性抑制MerTK和Axl可以阻碍癌症的进展,逆转突起瘤髓状细胞表型,并增强抗瘤免疫力.
研究的目的:
- 发现和描述A-910,一种新,强效和选择性的MerTK和AXL双抑制剂.
- 评估A-910作为癌症免疫疗法研究的口服生物可用工具化合物的潜力.
主要方法:
- 基于结构的药物化学活动以确定A-910.
- 评估化合物的效力,选择性,口服生物可用性和体内目标接触.
主要成果:
- 发现A-910,一种高效和选择性的双重MerTK/Axl抑制剂.
- A-910表现出良好的口服生物可用性和特殊的基因组选择性.
- 在体内观察到A-910.0具有显著的目标参与.
结论:
- A-910代表了一种有前途的新化学实体,用于向癌症中的TAM激酶.
- 该化合物的特性支持其作为体内工具用于探索癌症免疫治疗的双重MerTK/Axl抑制.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Receptor Tyrosine Kinases
12.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


